CASH COW

[BioSpecialist]

still trading significantly below cash ...She is on the move gain guys

Clearside Biomedical, Inc. (CLSD): Outperform Candidate With 330.88% Upside Potential

Clearside Biomedical, Inc. is maintained at an average outperform rating by 8 stock analysts, and there are at least 2.8% of shares outstanding that are currently legally short sold. The shares went up by 15.25% in value last month. Year-to-date it jumped 27.1%. Analysts are turning out to be more optimistic than before, with 5 of analysts who cover Clearside Biomedical, Inc. (NASDAQ:CLSD) advice adding it to buy candidate list. Wall Street experts also assign a $5.86 price target on Clearside Biomedical, Inc., pointing towards a 330.88% rally from current levels. The stock is trading for about -91.13% less than its 52-week high.

https://www.postanalyst.com/2019/02/11/sizzling-technical-charts-clearside-biomedical-inc-clsd-golden-entertainment-inc-gden/